CMS Open Payments · Program Year 2024
Microsurgical Technology, Inc.
Microsurgical Technology, Inc. reported $97,660.45 across General Payments, Research, and Ownership to 124 physicians and teaching hospitals across 124 transactions.
- $97.7K Below-median payer
- All-tracks total
- 124 Below-median volume
- Transactions
- 124 Below-median reach
- Recipients
- −$65.2K
- General Payments vs PY2023
Microsurgical Technology, Inc. reported $97,660.45 across all CMS Open Payments tracks (General + Research + Ownership) to 124 physicians and teaching hospitals in Program Year 2024 - ranking #1190 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $97,660.45, averaging $787.58 per recipient.
Microsurgical Technology, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
21/100
Total payments
F
11/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer microsurgical-technology-inc Microsurgical Technology, Inc.
$97.7K · #1190/1,925 · 0.0% industry · PY2024
- TOT $97.7K
- RANK #1190
- SHARE 0.0%
- TXN 124
- RCP 124
- CAT 4
- GEN $97.7K
- ΔGEN −$65.2K
- TOP1 35.0%
- PY 2024
Volume peers
Nearest volume peer: Podimetrics, Inc. ($97.6K)
Microsurgical Technology, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Microsurgical Technology, Inc.'s CMS-reported General Payments decreased by $65.2K (−40.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MICROSURGICAL TECHNOLOGY, INC.PY2023: MICROSURGICAL TECHNOLOGY, INC.PY2024: Microsurgical Technology, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $162,855.62
- PY2024
- $97,660.45
What the Data Shows for Microsurgical Technology, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Microsurgical Technology, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 4 general-payment categories charted below, "Consulting Fee" is the largest at $37.4K across 16 transactions, 38.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Microsurgical Technology, Inc. made 4 types of general payments. "Consulting Fee" is the largest category at $37.4K, 38.3% of General Payments.
Microsurgical Technology, Inc. reports 4 general-payment categories - the top three are Consulting Fee (38.3%), Royalty or License (36.1%), and Charitable Contribution (18.2%). The remaining 1 category make up 7.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Microsurgical Technology, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $37.4K | 16 | 38.3% |
| Royalty or License | $35.3K | 8 | 36.1% |
| Charitable Contribution | $17.7K | 18 | 18.2% |
| Food and Beverage | $7.3K | 82 | 7.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $57,353.09 (58.7%) of $97,660.45 in this company's General Payments records across 60 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Microsurgical Technology, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Steven Dewey
$34,155.98 across 4 reported transactions
- 2
Tomas Grippo
$10,000.00 across 4 reported transactions
- 3
Brandon Ayres
$5,000.00 across 2 reported transactions
- 4
Nicole Fram
$5,000.00 across 2 reported transactions
- 5
Christopher Pole
$3,197.11 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Microsurgical Technology, Inc.'s spend rank (#1190 of 1,925, bottom 38% by spend) and concentration rank (#879 of 1,838, top 48% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Nexus CMF, LLC : $69.0K total payments, HHI 1476
- Vertex Pharmaceuticals Incorporated : $6.9M total payments, HHI 1475
- Theragen, Inc. : $28.8K total payments, HHI 1475
- Ferring Pharmaceuticals AS : $71.5K total payments, HHI 1474
- Dunamis Medical, LLC : $6.0K total payments, HHI 1473
- Smaio SA : $32.3K total payments, HHI 1470
- Microsurgical Technology, Inc. (this company) : $97.7K total payments, HHI 1467
- Janssen Global Services, LLC : $1.8M total payments, HHI 1459
- Sequel Med Tech, LLC : $5.1K total payments, HHI 1455
- United Imaging Healthcare North America LLC : $51.7K total payments, HHI 1453
- Qapel Medical Inc : $256.6K total payments, HHI 1446
- CMS Imaging, Inc. : $44.5K total payments, HHI 1444
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Microsurgical Technology, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Microsurgical Technology, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Microsurgical Technology, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
OraBio, Inc.
Elite Orthopedics, Llc
McKesson Corporation
Thrombolex, Inc.
Medistim USA, Inc.
Put this to use
Microsurgical Technology, Inc. ranks #1190 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Microsurgical Technology, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.